zepbound weight loss news

Zepbound, obstructive sleep apnea and FDA

FDA approves weight-loss drug Zepbound for obstructive sleep apnea

The US Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the weight-loss drug Zepbound.

USA TODAY on MSN · 2d

The FDA on Friday approved Eli Lilly's weight-loss drug Zepbound as a treatment for moderate-to-severe sleep apnea and obesity.

ConsumerAffairs · 1h

FDA approves Zepbound as a treatment for obstructive sleep apnea

Zepbound is Eli Lilly’s weight loss drug. Now, it is also a drug to treat obstructive sleep apnea (OSA).The U.S. Food and Drug Administration has appro

CNN18d

Zepbound leads to more weight loss than Wegovy, drugmaker Eli Lilly says

That translates to an average weight loss of about 50 pounds for those taking Zepbound, compared with an average weight loss of 33 pounds for those taking Wegovy. People taking Zepbound ...

Healthline18d

Zepbound Leads to More Weight Loss Than Wegovy in Head-to-Head Clinical Trial

Share on Pinterest Drug manufacturer Eli Lilly says their drug Zepbound is more effective than Wegovy for long-term weight loss. Shelby Knowles/Bloomberg via Getty Images Zepbound led to more ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

Zepbound, obstructive sleep apnea and FDA

Trending now

Related topics